GOCOVRI (Adamas Pharma, LLC)
Welcome to the PulseAid listing for the GOCOVRI drug offered from Adamas Pharma, LLC. This Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Adamas Pharma, LLC |
NON-PROPRIETARY NAME: | AMANTADINE |
SUBSTANCE NAME: | AMANTADINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, COATED PELLETS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-08-24 |
END MARKETING DATE: | 0000-00-00 |
GOCOVRI HUMAN PRESCRIPTION DRUG Details:
Item Description | GOCOVRI from Adamas Pharma, LLC |
LABELER NAME: | Adamas Pharma, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 68.5(mg/1) |
START MARKETING DATE: | 2017-08-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70482-085_fc8ae634-62f8-4ef2-b01b-4f6ff25b59b5 |
PRODUCT NDC: | 70482-085 |
APPLICATION NUMBER: | NDA208944 |
Other AMANTADINE Pharmaceutical Manufacturers / Labelers: